Tectonic Therapeutic (TECX) Gains from Sales and Divestitures (2018 - 2026)
Tectonic Therapeutic (TECX) reported Gains from Sales and Divestitures of $51282.0 for Q1 2026, up 578.24% quarter-over-quarter from $7561.0 in Q4 2025.
Tectonic Therapeutic (TECX) Gains from Sales and Divestitures (2018 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 9 years of Gains from Sales and Divestitures data on file, last reported at $51282.0 in Q1 2026.
- Gains from Sales and Divestitures for Q1 2026 came in at $51282.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $51282.0 (changed N/A YoY), and the FY2025 annual result was $7561.0, down 70.72% from the prior year.
- Gains from Sales and Divestitures rose to $51282.0 in Q1 2026 per TECX's latest filing, from $7561.0 in the prior quarter.
- Over five years, Gains from Sales and Divestitures peaked at $305502.0 in Q4 2023 and troughed at $143.0 in Q1 2022.
- A 5-year average of $83301.1 and a median of $18968.0 in 2024 frame the typical range for Gains from Sales and Divestitures.
- The sharpest annual moves came in 2023 and 2024: Gains from Sales and Divestitures jumped 88213.59% in 2023, then sank 93.32% in 2024.
- A 5-year view of Gains from Sales and Divestitures shows it stood at $575.0 in 2022, then jumped by 53030.78% to $305502.0 in 2023, then plunged by 91.55% to $25827.0 in 2024, then tumbled by 70.72% to $7561.0 in 2025, then surged by 578.24% to $51282.0 in 2026.
- Business Quant data shows TECX's Gains from Sales and Divestitures at $51282.0 in Q1 2026, $7561.0 in Q4 2025, and $2930.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Tectonic Therapeutic | 528.16 Mn | 291.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51,282.00 |
| Mar 31, 2026 | 51,282.00 |
| Dec 31, 2025 | 7,561.00 |
| Dec 31, 2025 | 7,561.00 |
| Sep 30, 2025 | 2,930.00 |
| Sep 30, 2025 | 2,930.00 |
| Jun 30, 2025 | 2,930.00 |
| Jun 30, 2025 | 2,930.00 |
| Dec 31, 2024 | 25,827.00 |
| Dec 31, 2024 | 25,827.00 |
| Sep 30, 2024 | 18,968.00 |
| Sep 30, 2024 | 18,968.00 |
| Mar 31, 2024 | 190,973.00 |
| Mar 31, 2024 | 190,973.00 |
| Dec 31, 2023 | 305,502.00 |
| Dec 31, 2023 | 305,502.00 |
| Sep 30, 2023 | 283,835.00 |
| Sep 30, 2023 | 283,835.00 |
| Jun 30, 2023 | 253,460.00 |
| Jun 30, 2023 | 253,460.00 |